Law360

Amgen, Sandoz Battle Over High Court's Biosimilar Ruling

In the aftermath of the U.S. Supreme Court’s landmark biosimilars ruling, Amgen Inc. and Sandoz Inc. clashed late Monday over whether biosimilar makers can be punished for not divulging their approval applications to innovator rivals. ...read more